16/03/2023 – Presentation of the AB Science Microtubule Destabilizer Agents platform webcast Download PDF Post navigationPreviousPrevious post:AB Science will host a live webcast on its microtubule destabilizer agents (MDA) platform on Thursday March 16, 2023, from 6pm to 7pm CETRelated PostsAB Science will host a live webcast on its microtubule destabilizer agents (MDA) platform on Thursday March 16, 2023, from 6pm to 7pm CETMarch 15, 2023AB Science reports a first complete bone marrow response in a relapsed refractory acute myeloid leukemia patient from the very low dose arm of its AB8939 Phase I/II clinical trial (AB18001)March 13, 2023Publication of the masitinib pivotal phase 3 clinical trial in Alzheimer’s Disease in the journal Alzheimer’s Research & TherapyFebruary 28, 2023AB Science announces the drawdown of the second tranche of 6 million euros under its financing agreement with the European Investment BankJanuary 31, 2023
AB Science will host a live webcast on its microtubule destabilizer agents (MDA) platform on Thursday March 16, 2023, from 6pm to 7pm CETMarch 15, 2023
AB Science reports a first complete bone marrow response in a relapsed refractory acute myeloid leukemia patient from the very low dose arm of its AB8939 Phase I/II clinical trial (AB18001)March 13, 2023
Publication of the masitinib pivotal phase 3 clinical trial in Alzheimer’s Disease in the journal Alzheimer’s Research & TherapyFebruary 28, 2023
AB Science announces the drawdown of the second tranche of 6 million euros under its financing agreement with the European Investment BankJanuary 31, 2023
